Ignite Creation Date:
2025-12-24 @ 11:51 PM
Ignite Modification Date:
2026-02-02 @ 4:28 AM
Study NCT ID:
NCT00522951
Status:
COMPLETED
Last Update Posted:
2017-08-28
First Post:
2007-08-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
SH L 562BB Phase II/III Dose Justification and Gadoteridol-controlled Comparative Study
Sponsor:
Bayer
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
91569
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None